These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25739551)

  • 21. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
    Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
    Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
    Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
    Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
    Wu SW; Ma CC; Li WH
    Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
    König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR
    Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
    Uner A; Ebinc FA; Akyurek N; Unsal D; Mentes BB; Dursun A
    Exp Oncol; 2005 Sep; 27(3):225-8. PubMed ID: 16244586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of HER3 is associated with a decreased survival in gastric cancer.
    Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
    Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.
    Styczen H; Nagelmeier I; Beissbarth T; Nietert M; Homayounfar K; Sprenger T; Boczek U; Stanek K; Kitz J; Wolff HA; Ghadimi BM; Middel P; Liersch T; Rüschoff J; Conradi LC
    Oncotarget; 2015 Jun; 6(17):15065-76. PubMed ID: 25915155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.
    Zemzoum I; Kates RE; Ross JS; Dettmar P; Dutta M; Henrichs C; Yurdseven S; Höfler H; Kiechle M; Schmitt M; Harbeck N
    J Clin Oncol; 2003 Mar; 21(6):1022-8. PubMed ID: 12637466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    Falck AK; Fernö M; Bendahl PO; Rydén L
    World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
    Galdy S; Lamarca A; McNamara MG; Hubner RA; Cella CA; Fazio N; Valle JW
    Cancer Metastasis Rev; 2017 Mar; 36(1):141-157. PubMed ID: 27981460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.
    Yan Q; Guo K; Feng G; Shan F; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Medicine (Baltimore); 2018 Sep; 97(37):e12317. PubMed ID: 30212974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
    Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
    Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer].
    Li G; Gu RM; Wen X; Ming XZ; Xia L; Xu XY; Zhang J; Chen HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):668-72. PubMed ID: 23888453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.
    Dandachi N; Dietze O; Hauser-Kronberger C
    Anticancer Res; 2004; 24(4):2401-6. PubMed ID: 15330190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma: Prognostic relevance.
    Peiró G; Aranda FI; Adrover E; Niveiro M; Alenda C; Payá A; Seguí J
    Hum Pathol; 2007 Jan; 38(1):26-34. PubMed ID: 17056098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in HER2 expression between primary colorectal cancer and corresponding metastases.
    Shan L; Lv Y; Bai B; Huang X; Zhu H
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2275-2281. PubMed ID: 30203148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
    Lee HJ; Chung JY; Hewitt SM; Yu E; Hong SM
    Virchows Arch; 2012 Nov; 461(5):521-30. PubMed ID: 23052372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.